Market Place
Sourcing Support
AstraZeneca calls off two late-stage potassium drug trials
02 Dec 2023 //
REUTERS
LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia
17 Nov 2021 //
BUSINESSWIRE
Lokelma label update approved in China for patients with hyperkalaemia
24 Nov 2020 //
PRESS RELEASE
EU approves label update for AZ` Lokelma
04 May 2020 //
PHARMATIMES
Lokelma US label updated to include dosing guidance for hyperkalaemia
27 Apr 2020 //
ASTRAZENECA
China approves AstraZeneca`s Lokelma to treat hyperkalaemia
08 Jan 2020 //
BIOSPECTRUM ASIA
NICE turns down hyperkalaemia therapies
30 Oct 2018 //
PHARMA TIMES
AZ gets US approval for Veltassa rival Lokelma
21 May 2018 //
PMLIVE
LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia
18 May 2018 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.